Lv1
90 积分 2022-12-15 加入
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
6小时前
待确认
A memristor-based adaptive neuromorphic decoder for brain–computer interfaces
1个月前
已完结
DNMTi@ZIF-8 Enhances Biomimetic Pulp Regeneration via Epigenetic Regulation
1个月前
已完结
Bifunctional P450 Catalyzes Sequential Hydroxylation and Macrocyclization in Emestrin A Biosynthesis
1个月前
已完结
A novel MST1-targeting kinsenoside derivative K30 attenuates acute kidney injury by restoring mitochondrial homeostasis
1个月前
已完结
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
1个月前
已完结
Novel treatment strategies for chronic myeloid leukemia
3个月前
已完结
Asciminib: the tyrosine kinase inhibitor with a unique mechanism of action
3个月前
已完结
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
3个月前
已完结
Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring
3个月前
已完结
皖公网安备34019202002308
